LSBCF — LakeShore Biopharma Co., Ltd.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1946399 ·
Last close
$0.07
Market Cap
$2.88M
52W High
$0.07
52W Low
$0.03
ADV30
5,713
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2025 | — | — | — | — | 1,367,663,211 | 28,083,556 | 867,908,580 |
| Sep 2024 | — | — | — | — | 1,432,623,000 | 49,466,000 | 830,080,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,407,485,287
Inventory
$227,591,892
Receivables
$501,790,254
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$614,961,600
EBITDA
$-12,925,235
Free Cash Flow
$-210,463,216
Enterprise Value
$180,998,304
Total Cash
$246,351,232
Total Debt
$424,464,640
Shares Out
41,212,693
Trailing EPS
$-0.77
Book Value
$3.49
ROE
-18.4%
ROA
-2.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 614,961,584 | -44,451,277 | -99,982,451 | 1,367,663,211 | 867,908,580 | — | -120,981,727 |
| Mar 2024 | 573,418,256 | -267,707,849 | -433,464,871 | 1,513,027,356 | 927,821,054 | — | -295,229,603 |
| Mar 2023 | 687,201,070 | -104,654,347 | -145,479,105 | 1,719,753,611 | 991,300,326 | — | -182,469,396 |
| Mar 2022 | 502,949,894 | -86,461,896 | -106,004,401 | 1,441,753,141 | 2,140,722,329 | — | -173,545,357 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | $3.08M | $0.15 | — |
| PPBT | PURPLE BIOTECH LTD. | $2.70M | $2.90 | — |
| VCNX | VACCINEX, INC. | $2.68M | $1.00 | — |
| OGEN | ORAGENICS INC | $2.67M | $0.59 | — |
| LIFD | LFTD PARTNERS INC. | $2.67M | $0.18 | — |
News headlines (Yahoo Finance, 1h cache)
LakeShore Biopharma Enters Into Amended Merger Agreement for Going-Private Transaction
2026-04-29 12:00 · Yahoo
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
2026-03-25 12:00 · Yahoo
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
2026-02-06 12:00 · Yahoo
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
2026-01-20 12:00 · Yahoo
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
2025-11-04 12:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.